• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form PX14A6G filed by Centene Corporation

    4/11/25 2:27:04 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    PX14A6G 1 i411251px14a6g.htm

     

     

     

     

     

    Notice of Exempt Solicitation Pursuant to Rule 14a-103

    Name of Registrant: Centene Corporation (CNC)

    Name of person relying on exemption: John Chevedden, Centene Shareholder since 2019

    Address of persons relying on exemption: POB 2673, Redondo Beach, CA 90278

     

    These written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934. John Chevedden does not beneficially own more than $5 million of the class of subject securities, and this notice of exempt solicitation is therefore being provided on a voluntary basis.

     

    This is not a solicitation of authority to vote your proxy.

     

    Please DO NOT send me your proxy card; the shareholder is not able to vote your proxies, nor does this communication contemplate such an event.

     

    The shareholder asks all shareholders to vote by following the procedural instructions provided in the proxy materials. 

     

     

     

    Please Support Item #5 to Disclose Plan to Reduce Total Contribution to Climate Change

     

    To Centene Shareholders:

     

    I ask shareholders to vote FOR Item 5 at the Centene shareholder meeting on May 13, 2025. The proposal asks Centene (“the Company”) to disclose a report on its plans for reducing its contribution to climate change:

     

    RESOLVED: Shareholders request that Centene issue a report (at reasonable cost, omitting proprietary information) describing if, and how, it plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement’s ambition of limiting global temperature rise.

     

    SUPPORTING STATEMENT: In the report shareholders seek information, at board and management discretion, on the relative benefits and drawbacks of integrating the following actions:

     

    ·Adopting science-based GHG emission reduction targets for the Company's full range of operational and value chain emissions, taking into consideration criteria used by advisory groups like the Science Based Targets initiative;

     

      
     

     

    ·Developing a transition plan that shows how the Company plans to meet its goals, taking into consideration criteria used by advisory groups such as the Transition Plan Taskforce, Task Force for Climate-Related Financial Disclosures, CDP, Climate Action 100+, and Ceres; and
    ·Adopting supporting targets for renewable energy, energy efficiency, supply chain engagement, or other measures deemed appropriate by management.

     

    1.Centene acknowledges that climate change poses risks to its business.

     

    In order to limit warming to 1.5 °C and prevent the worst impacts of climate change, emissions must be cut in half by 2030 and reach net zero by 2050. Rising temperatures associated with climate change not only increase the frequency of extreme weather events, which may pose physical risks to Centene’s operations, but also exacerbate health hazards by worsening air quality,1 augmenting heat-related illnesses,2 and spreading vector-borne diseases.3 Centene has analyzed various climate drivers and identified a myriad of negative health outcomes that may arise from them, which could impact the Company’s margins as global temperatures continue to increase.4 Indeed, Centene notes in its most recent 10-K that the effects of climate change “could reduce our ability to accurately predict and effectively control the costs of providing health benefits.”5 The Company’s opposition statement identifies the “increasing regulatory and political uncertainty regarding disclosure and management of climate-related risks” as a reason to vote against this proposal. However, these changing dynamics do not affect the imperative to mitigate the material financial risks that climate change poses to Centene’s business, investor portfolios, and the global economy.

     

    2.Centene does not have a long-term climate mitigation strategy aligned with the Paris Agreement’s ambition to limit warming to 1.5 °C, and this proposal provides the Company with flexibility in its approach.

     

    While Centene’s emissions reduction efforts to date are commendable, the Company has not set targets for continuing progress in the near term or reaching net zero in the long term. Setting forward-looking goals is especially relevant as a large portion of the Company’s scope 1 and 2 reductions appear to have resulted from its reduced real estate footprint. While this created reductions in the Company’s emissions accounting, it is unclear whether Centene’s emissions have declined per square foot across its remaining real estate footprint or whether this action translated to fewer real-world emissions. Furthermore, over 80% of Centene’s emissions fall into scope 3, purchased goods and services, for which the Company has not described any efforts to reduce its supply chain emissions. Additional progress may require actions such as renewable energy procurement and supply chain engagement, which require careful planning and dedication of resources. Both these actions could, as examples, result in lower energy costs, increased resilience, and strengthened supplier relationships for the Company.

    _____________________________

    1 https://www.epa.gov/climateimpacts/climate-change-impacts-air-quality

    2 https://www.nejm.org/doi/full/10.1056/NEJMra2210769

    3 https://www.cdc.gov/climate-health/php/effects/vectors.html

    4 https://www.centene.com/content/dam/centenedotcom/documents/TCFD-Index-2024.pdf

    5 https://www.sec.gov/ix?doc=/Archives/edgar/data/1071739/000107173924000037/cnc-20231231.htm

     

      
     

     

     

    The proponent supports the Company’s desire to maintain “flexibility to choose from among appropriate sustainability initiatives and the timing for the implementation of those initiatives," as expressed in the opposition statement. This proposal does not seek to prescribe specific emissions reduction strategies or impose a particular timeline for setting targets, providing latitude to the Company regarding implementation. Rather, the proposal seeks a report to understand if, and how, Centene will continue to reduce its climate impacts and mitigate associated risks going forward.

     

    3.The Company lags peers in setting GHG reduction targets.

     

    Industry peers have high ambitions for GHG reduction. CVS Health (Aetna) and UnitedHealth Group have set and committed to set, respectively, both near-term and net zero targets through the Science Based Targets initiative (SBTi). Cigna also committed to set near-term targets through the SBTi this past summer.6 Elevance Health aims to achieve net zero by 2050 and notes, “we engage our top 80% of suppliers by spend on setting their own science-based emissions reduction targets.” Elevance Health is a signatory to RE100, a corporate renewable energy initiative, and has used 100% renewable energy to power its operations since 2021, 4 years ahead of its 2025 target year.7 The proposal recommends that Centene assess setting targets through the SBTi, which would provide the Company a full two years after making the initial commitment to set targets and identify appropriate strategies to achieve them.

     

     

    Vote “Yes” on Shareholder Proposal #5

     

    _____________________________

    6 https://sciencebasedtargets.org/target-dashboard

    7 https://www.elevancehealth.com/content/dam/elevance-health/documents/ELV_2023_Impact_Report.pdf

     

     

     

     

     

     

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    More analyst ratings

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    2/5/26 8:52:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CENTENE CORP (0001071739) (Filer)

    11/10/25 4:40:53 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    11/5/25 11:30:18 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief People Officer Mcnally Tanya M was granted 74,311 shares, increasing direct ownership by 131% to 131,007 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:13 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Corporate Controller & CAO Casso Katie was granted 26,036 shares, increasing direct ownership by 30% to 113,135 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:20 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Chief Operating Officer Smith Susan Raye was granted 112,823 shares, increasing direct ownership by 110% to 215,638 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:08 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative

    More than 1 million students in the U.S. will participate in the program, organized by Sandy Hook Promise. AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- For the past decade, Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE:CNC), has worked with local schools to bring the No One Eats Alone® (NOEA) program to Texas students. This February, Superior is partnering with 20 schools to host events to help young people better understand the effects of social isolation. The Centene Foundation, the philanthropic arm of Centene, sponsors the program.

    2/11/26 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Absolute Total Care receives 2025 Press Ganey Human Experience Pinnacle of Excellence Award®

    Absolute Total Care is recognized as an industry leader in Member Experience COLUMBIA, S.C., Feb. 9, 2026 /PRNewswire/ -- Absolute Total Care today announced that it has been named a 2025 Human Experience (HX) Pinnacle of Excellence Award® winner by Press Ganey, the global leader in healthcare experience solutions and services. This award is part of Press Ganey's annual ranking of the top health plans, hospitals and health systems in the country, according to performance in a variety of experience metrics. As a winner of the Press Ganey HX Pinnacle of Excellence Award®, Absolute Total Care has earned recognition for ranking in the top 5% of health plans nationwide, delivering exceptional me

    2/9/26 3:39:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Health Net and Pro Football Hall of Fame Honor Sacramento Community and Inspire Local Youth During Super Bowl Week

    'Salute to Service' and 'Strong Youth, Strong Communities' Events Bring Pro Football Legends to Sacramento and West Sacramento SACRAMENTO, Calif., Feb. 6, 2026 /PRNewswire/ -- On Wednesday, February 4, Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), teamed up with the Pro Football Hall of Fame to celebrate the lead-up to Super Bowl Sunday with two impactful events in the Sacramento region: "Salute to Service" and "Strong Youth, Strong Communities." These annual gatherings, held near the Super Bowl host city, recognize local heroes and empower the next generation with inspiration and guidance.

    2/6/26 11:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Centene upgraded by Barclays with a new price target

    Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00

    1/5/26 8:29:16 AM ET
    $CNC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Centene with a new price target

    Goldman initiated coverage of Centene with a rating of Sell and set a new price target of $33.00

    10/14/25 8:47:32 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under

    1/13/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

    -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

    10/29/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care